(Q35219417)

7 August 2017

1 reference

title

Insulin therapy for type 2 diabetes. (English)

1 reference

7 August 2017

1 reference

1 reference

Afshin Sasali

1

1 reference

PubMed ID

12975027

7 August 2017

Jack L Leahy

series ordinal

2

1 reference

7 August 2017

1 October 2003

1 reference

7 August 2017

Current diabetes report

1 reference

7 August 2017

3

1 reference

7 August 2017

5

1 reference

7 August 2017

378-385

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-003-0081-2

7 August 2017

0 references

cites work

A diabetes report card for the United States: quality of care in the 1990s

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0081-2

The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0081-2

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0081-2

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0081-2

Novel insulins and strict glycemic control. Analogues approximate normal insulin secretory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0081-2

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0081-2

Inhaled human insulin treatment in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0081-2

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

21 January 2018

1 reference

12 December 2020

Combination of insulin and metformin in the treatment of type 2 diabetes

1 reference

12 December 2020

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

1 reference

12 December 2020

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

1 reference

12 December 2020

Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients

1 reference

12 December 2020

Novel insulins: expanding options in diabetes management

1 reference

12 December 2020

Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment

1 reference

12 December 2020

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

12 December 2020

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

1 reference

12 December 2020

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial

1 reference

12 December 2020

The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspecified hyperglycemia

1 reference

12 December 2020

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group

1 reference

12 December 2020

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

1 reference

12 December 2020

Clinical practice. Initial management of glycemia in type 2 diabetes mellitus

1 reference

12 December 2020

Using new insulin strategies in the outpatient treatment of diabetes: clinical applications

1 reference

12 December 2020

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

1 reference

12 December 2020

Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin

1 reference

12 December 2020

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

12 December 2020

Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes

1 reference

12 December 2020

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.

1 reference

12 December 2020

Timely addition of insulin to oral therapy for type 2 diabetes

1 reference

12 December 2020

Traffic hypoglycaemias and accidents in patients with diabetes mellitus treated with different antidiabetic regimens.

1 reference

12 December 2020

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes

1 reference

12 December 2020

Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes

1 reference

12 December 2020

Global and societal implications of the diabetes epidemic

1 reference

12 December 2020

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

12 December 2020

Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review

1 reference

12 December 2020

Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice

1 reference

12 December 2020

Combination therapies with insulin in type 2 diabetes

1 reference

12 December 2020

When oral agents fail: practical barriers to starting insulin

1 reference

12 December 2020

Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.

1 reference

12 December 2020

Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity

1 reference

12 December 2020

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

1 reference

12 December 2020

Economic costs of diabetes in the US in 2002.

1 reference

12 December 2020

Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes

1 reference

12 December 2020

Hypoglycemia in diabetes.

1 reference

12 December 2020

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Progression of retinopathy in insulin-treated type 2 diabetic patients

1 reference

12 December 2020

Evaluation of alternative strategies for optimizing glycemia: progress to date

1 reference

12 December 2020

10.1007/S11892-003-0081-2

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12975027